Combination Therapy for Chronic Hepatitis B Using Capsid Recycling Inhibitor
In this paper, we investigate the dynamics of hepatitis B virus infection taking into account the implementation of combination therapy through mathematical modeling. This model is established considering the interplay between uninfected cells, infected cells, capsids, and viruses. Three drugs are considered for specific roles (i) pegylated interferon (PEG IFN) for immune modulation, (ii) lamivudine (LMV) as a reverse-transcriptase inhibitor, and (iii) entecavir (ETV) to block capsid recycling. Using these drugs, three combination therapies are introduced, specifically CT PEG IFN plus LMV, CT PEG IFN plus ETV, and CT PEG IFN plus LMV plus ETV. As a result, when LMV is used in combination therapy with PEG IFN and ETV, the impacts of ETV become insignificant. In conclusion, if the appropriate drug effectively inhibits reverse transcription, there is no need for an additional inhibitor to block capsid recycling.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Understanding Hepatitis B Virus Infection through Hepatocyte Proliferation and Capsid Recycling
Proliferation of uninfected as well as infected hepatocytes and recycling of DNA-containing capsids are two major mechanisms playing significant roles in the clearance of hepatitis B virus (HBV) infection. In this study,…
Multi-point Infection Dynamics of Hepatitis B in the Presence of Sub-Viral Particles
Hepatitis B virus (HBV) is considered as etiological agent of the lethal liver disease hepatitis B. Globally, hepatitis B is recognized as one of the prevailing infectious diseases with a significant impact on human heal…
Exploration of Hepatitis B Virus Infection Dynamics through Virology-Informed Neural Network: A Novel Artificial Intelligence Approach
In this work, we introduce Virology-Informed Neural Networks (VINNs), a powerful tool for capturing the intricate dynamics of viral infection when data of some compartments of the model are not available. VINNs, an exten…
VirologyRenal function changes in chronic hepatitis B patients
The best way to treat chronic hepatitis B is with pegylated interferon alone or with oral antiviral drugs. There is limited research comparing the renal safety of entecavir and tenofovir when used with pegylated interfer…
Role of dynamic capsomere supply for viral capsid self-assembly
Many viruses rely on the self-assembly of their capsids to protect and transport their genomic material. For many viral systems, in particular for human viruses like hepatitis B, adeno or human immunodeficiency virus, th…